Skip to main content
[Podcast] How Can Cell & Gene Manufacturers Scale to Meet Demand?

[Podcast] How Can Cell & Gene Manufacturers Scale to Meet Demand?

In this episode of Exceeding Your Benchmark, Sumit Verma, Senior Vice President Global Strategic Manufacturing at Iovance Biotherapeutics, talks about the challenges faced by new biopharma startups and how cell and gene manufacturers can scale to meet demand.

Learn More
[Podcast] What Updated Annex 1 Regulations Mean for Sterile Manufacturing Companies in 2023

[Podcast] What Updated Annex 1 Regulations Mean for Sterile Manufacturing Companies in 2023

Podcast Host Gabrielle Bejarano talked to Chris White, who is the Global Head of GMP at Adamas Consulting, about what’s new and different in Annex 1, and how sterile manufacturing companies and facilities can meet the regulations by the summer of 2023.

Learn More
How to Prevent Endotoxin Contamination in Sterile Pharmaceutical Manufacturing

How to Prevent Endotoxin Contamination in Sterile Pharmaceutical Manufacturing

In pharmaceutical manufacturing, the presence of endotoxin poses a risk to final product quality and patient safety. This article will discuss what endotoxins are, how they can be detected, and how you can prevent contamination.

Learn More
3 Crucial Factors to Achieve Annex 1 Compliance

3 Crucial Factors to Achieve Annex 1 Compliance

On August 25th 2022, the FDA alongside EMA jointly released its new Annex 1 regulations for sterile drug manufacturing processes, monitoring, quality control, and more. The revision has been 14 years in the making, and largely overhauls the original 2008 good manufacturing practices with the aim of reflecting the changes of evolving manufacturing processes. The new regulations take effect on August…

Learn More
Annex 1: How Will the Revisions Effect Compliance of Your Cleanroom Facilities?

Annex 1: How Will the Revisions Effect Compliance of Your Cleanroom Facilities?

After several years of delays, the EU and FDA are now doubling down on their efforts to force drug manufacturers to comply with Annex 1…

Learn More